Apoptosis rate, measured by terminal transferase dUTP nick-end labeling assay, after treatment with imatinib, nilotinib and transfection with BCR-ABL siRNA or co-treatment with BCR-ABL siRNA and imatinib or nilotinib in tyrosine kinase inhibitor-sensitive and –resistant BCR-ABL oligoclonal cell lines.